On March 1, 2019 Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported that it is scheduled to present at the following upcoming events (Press release, Arrowhead Pharmaceuticals, MAR 1, 2019, View Source [SID1234533876]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Barclays Global Healthcare Conference 2019 – Miami, March 12-14, 2019
March 12, 4:20 p.m. EDT –Bruce Given, M.D., Arrowhead’s chief operating officer, will deliver a corporate presentation
Jefferies HBV Investor Summit – New York, March 18, 2019
March 18, 9:30 a.m. EDT – Dr. Given will participate in a fireside chat presentation with Maury Raycroft, Ph.D., Jefferies Biotech Analyst
Oligonucleotide & Precision Therapeutics (OPT) Congress– Cambridge, MA, March 26-27, 2019
March 26, 4:35 p.m. EDT –James Hamilton, M.D., Arrowhead’s vice president of clinical development, will deliver an oral presentation titled, "siRNA Clinical Development Based on the TRiM Platform"
CSHL Meeting: RNA & Oligonucleotide Therapeutics – Cold Spring Harbor, NY, March 27-30, 2019
Dr. Hamilton will deliver an oral presentation titled, "Cardiovascular and lipid disorders – A next frontier for TRiM RNAi"
AACR Annual Meeting 2019 – Atlanta, March 29 – April 3, 2019
April 3, 8:00 a.m. EDT – So Wong, Ph.D., Arrowhead’s director of oncology, will deliver a poster presentation titled, "Optimizing the potency and dosing design for ARO-HIF2: An RNAi therapeutic for clear cell renal cell carcinoma"
A copy of the presentation materials and webcast links, if the presentation is being webcast, may be accessed on the Events and Presentations page under the Investors section of the Arrowhead website.